Edgewise Therapeutics Inc (EWTX) Stock Analysis

Edgewise Therapeutics Inc (EWTX) is a publicly traded company in the HEALTHCARE sector. It trades at $37.25, carries a market capitalization of $3.68B. This page summarizes the public market data, fundamentals, and frequently asked questions for EWTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Edgewise Therapeutics Inc currently has a Bullish sentiment score of 0.18.

About Edgewise Therapeutics Inc

Edgewise Therapeutics, Inc. is a biopharmaceutical company headquartered in Boulder, Colorado, dedicated to developing novel small molecule therapies for musculoskeletal diseases. Utilizing its proprietary platform, the company focuses on delivering precision medicine solutions that address significant unmet medical needs, particularly in muscle disorders and bone injuries. With a robust pipeline of transformative treatments, Edgewise Therapeutics is poised to advance the field of orthopedics...

GNG Research Analysis

GNG Research scores Edgewise Therapeutics Inc (EWTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EWTX.

Frequently Asked Questions

Does EWTX pay dividends?

Edgewise Therapeutics Inc (EWTX) does not currently pay a regular dividend.

What is EWTX's market cap?

Edgewise Therapeutics Inc (EWTX) has a market capitalization of $3.68B with a current stock price of $37.25.